Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag Used in Thrombocytopenia After Consolidation Therapy in Acute Myeloid Leukemia (AML)
NCT03701217Phase 3Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Sep 2018
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of eltrombopag in Thrombocytopenia, sponsored by Nanfang Hospital, Southern Medical University. Status: unknown.
02
Drugs
eltrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT03701217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03701217.